Emilia Perez-Alors
Cordoba, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Metformin improves hepatic steatosis in diet induced obese FVB/N mice: Alterations of glucose metabolism and hepatic splicing machinery.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 11, 2025
Exploring RNA biology in pseudomyxoma peritonei uncovers splicing dysregulation as a novel, targetable molecular vulnerability.
Journal: Cancer gene therapy
Published: December 05, 2024
Splicing Machinery Is Impaired in Oral Squamous Cell Carcinomas and Linked to Key Pathophysiological Features.
Journal: International journal of molecular sciences
Published: May 30, 2024
Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 23, 2023
Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery.
Journal: Journal of translational medicine
Published: May 05, 2023
Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets.
Journal: Molecular oncology
Published: April 14, 2023
Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response.
Journal: Molecular therapy. Nucleic acids
Published: February 09, 2023
The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities.
Journal: Reviews in endocrine & metabolic disorders
Published: November 15, 2022
Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: March 11, 2022
Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing.
Journal: Clinical and translational medicine
Published: September 28, 2021
Last Updated: 09/26/2026